EquityPanditβs Outlook forΒ Sun Pharma for the weekΒ Β (June 25, 2018Β βΒ June 29, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
EquityPanditβs Outlook forΒ Sun Pharma for the weekΒ Β (June 18, 2018Β βΒ June 22, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
Sun Pharma has receivedΒ the Establishment Inspection Report (EIR), for its Halol plant in Gujarat fromΒ the US Food and Drug Administration. In a statementΒ to the exchanges...
EquityPanditβs Outlook forΒ Sun Pharma for the weekΒ Β (June 11, 2018Β βΒ June 15, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
EquityPanditβs Outlook forΒ Sun Pharma for the weekΒ Β (June 04, 2018Β βΒ June 08, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
EquityPanditβs Outlook forΒ Sun Pharma for the weekΒ Β (May 28, 2018Β βΒ June 01, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on negative note losing...
Sun Pharmaceutical’s consolidated net profit rose 6.94% YoY to Rs.1,309 crore, in the quarter ended March 31,2018. The company’s consolidated revenue for the quarter under...
Sun Pharmaceuticals has received the USFDA approval for a drug named YONSA. YONSA is a novel formulation in combination with methylprednisolone, for the treatment of...
EquityPanditβs Outlook forΒ Sun Pharma for the weekΒ Β (May 21, 2018Β βΒ May 25, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on negative note losing...
EquityPanditβs Outlook forΒ Sun Pharma for the weekΒ Β (May 14, 2018Β βΒ May 18, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on negative note losing...